Skip to main content

Table 4 Respondents’ scores on importance of specific elements in information brought by pharmaceutical sales representatives (scale: 1–10; n = 200)

From: Knowledge transfer: what drug information would specialist doctors need to support their clinical practice? Results of a survey and of three focus groups in Italy

  Average score % scoring at least 8/10
Availability of RCTs vs placebo 8.1 81 %
Use of absolute risk differences 8.0 79 %
Availability of RCTs vs best alternative treatment 8.0 77 %
Detailed information about patient characteristics 8.0 76 %
Availability of systematic reviews 7.9 75 %
Availability of RCTs not sponsored by drug companies 7.9 74 %
Indication of the added value of drugs under study 7.9 71 %